Zobrazeno 1 - 10
of 36
pro vyhledávání: '"Jennifer Kendall"'
Autor:
Jason B Harris, Michael J Podolsky, Taufiqur R Bhuiyan, Fahima Chowdhury, Ashraful I Khan, Regina C Larocque, Tanya Logvinenko, Jennifer Kendall, Abu S G Faruque, Cathryn R Nagler, Edward T Ryan, Firdausi Qadri, Stephen B Calderwood
Publikováno v:
PLoS Neglected Tropical Diseases, Vol 3, Iss 3, p e403 (2009)
Infection with intestinal helminths is common and may contribute to the decreased efficacy of Vibrio cholerae vaccines in endemic compared to non-endemic areas. However, the immunomodulatory effects of concomitant intestinal parasitic infection in ch
Externí odkaz:
https://doaj.org/article/72f14dd622c04d169f305c3fe483b565
Autor:
Jennifer Kendall Sanders
Publikováno v:
Theological Studies. 81:849-869
Recent scholarship uses the metaphor of language to articulate why, even with good intentions, we Christians can hand on meanings and values at odds with the Christian message. Our “native” languages foreground our worlds, readily conforming our
Autor:
Euridice Carmona, Anne-Marie Mes-Masson, Laudine Communal, Amélie St-Georges-Robillard, Jennifer Kendall-Dupont, Benjamin Péant, Dina Dorrigiv, Kayla Simeone, Thomas Gervais
Publikováno v:
Cancers, Vol 13, Iss 4208, p 4208 (2021)
Cancers
Volume 13
Issue 16
Cancers
Volume 13
Issue 16
Simple Summary Cancer drugs have the lowest success rate of approval in drug development programs. In order to address this, predictive preclinical assays that correctly reflect the clinical efficacy of a drug represent an urgent need in both clinica
Autor:
Euridice Carmona, Maxime Cahuzac, Anne-Marie Mes-Masson, Hubert Fleury, Sophie Gilbert, Jennifer Kendall-Dupont, Zied Boudhraa, Kossay Zaoui, Diane Provencher, Guergana Tchakarska
Publikováno v:
Oncogene
While aneuploidy is a main enabling characteristic of cancers, it also creates specific vulnerabilities. Here we demonstrate that Ran inhibition targets epithelial ovarian cancer (EOC) survival through its characteristic aneuploidy. We show that indu
Autor:
Manon de Ladurantaye, Diane Provencher, Meriem Chergui, Anne-Marie Mes-Masson, Kayla Simeone, Jennifer Kendall-Dupont, Kurosh Rahimi, Alexandre Sauriol, Euridice Carmona, Lise Portelance, Kim Leclerc-Desaulniers, Liliane Meunier
Publikováno v:
Cancers
Volume 12
Issue 8
Cancers, Vol 12, Iss 2222, p 2222 (2020)
Volume 12
Issue 8
Cancers, Vol 12, Iss 2222, p 2222 (2020)
Cancer cell lines are amongst the most important pre-clinical models. In the context of epithelial ovarian cancer, a highly heterogeneous disease with diverse subtypes, it is paramount to study a wide panel of models in order to draw a representative
Publikováno v:
Evidence-Based Practice. 25:19-20
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Sanders, Jennifer Kendall
Publikováno v:
Lonergan Review; 2022, Vol. 12, p123-146, 24p
Autor:
Andrew W.B. Craig, Charles H. Graham, Cécile Le Page, Anne-Marie Mes-Masson, Julie-Ann Francis, Katrina K Au, Kathrin Tyrishkin, Runhan Ren, Liliane Meunier, Nichole Peterson, Madhuri Koti, Jeremy A. Squire, Jennifer Kendall-Dupont, Timothy Childs, Isabelle Clément
Publikováno v:
Repositório Institucional da USP (Biblioteca Digital da Produção Intelectual)
Universidade de São Paulo (USP)
instacron:USP
The Journal of Pathology: Clinical Research
Universidade de São Paulo (USP)
instacron:USP
The Journal of Pathology: Clinical Research
High‐grade serous ovarian carcinoma (HGSC) accounts for 70% of all epithelial ovarian cancers but clinical management is challenged by a lack of accurate prognostic and predictive biomarkers of chemotherapy response. This study evaluated the role o
Autor:
Adriana Mari Orimoto, Mohammad Abdul Lateef, Benjamin Péant, Diane Provencher, Robin Guay-Lord, Euridice Carmona, Anne-Marie Mes-Masson, Kayla Simeone, Fred Saad, Jennifer Kendall-Dupont, Thomas Gervais
Publikováno v:
Lab on a chip. 19(4)
There is an urgent need and strong clinical and pharmaceutical interest in developing assays that allow for the direct testing of therapeutic agents on primary tissues. Current technologies fail to provide the required sample longevity, throughput, a